PhaseBio Pharmaceuticals PHAS
$ 0.13
7.4%
Quarterly report 2022-Q2
added 08-12-2022
PhaseBio Pharmaceuticals Total Current Liabilities 2011-2024 | PHAS
Annual Total Current Liabilities PhaseBio Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
27.9 M | 15 M | 8.48 M | 4.58 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
27.9 M | 4.58 M | 14 M |